CV Sciences, Inc. (OTCQB:CVSI) a hemp-focused wellness company announced on Tuesday its financial results for the second quarter that ended June 30, 2024, revealing a flat revenue year-over-year at $4 million for the period. "Revenues for our core business remained stable at $4 million in the second quarter of 2024 despite a challenging environment," said CEO Joseph Dowling. "With our recently completed acquisitions and new product innovations, we are planning to grow our revenue in the second half of 2024. Our 47.0% gross margin in the second quarter of 2024 is our best gross margin in the last 13 ...